Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Sugee Group showcases enthusiastic participation in Dadar Beach Clean – up Drive 2023 Business
  • Bit CapitalX Honors Outstanding Business Leaders at the Prestigious Leaders Excellence Awards 2025 in Dubai Business
  • Assurance Intl Ltd Extends Its Licensing With Goodyear, Introducing New Categories In Auto Parts, Car Care Products And Car Accessories Business
  • SBI-SG Global Securities Services Pvt. Ltd. Spearheads CSR Initiative to Refurbish Sukh Shanti Shelter Home in Mumbai, Maharashtra Business
  • Trehan Media and Adio Brand Solutions Win Co-Branding Rights for 14 Iconic Delhi Metro Stations: A New Chapter in Urban Brand Engagement Business
  • The Nykaa Summer Super Saver Days Are Here! Lifestyle
  • Sankalp India Launches 10-Bed Bone Marrow Transplant Unit for Children with Blood Disorders in Ahmedabad Health
  • A Day in the Life of a Himalayan School Student Reflects the Changing Face of Online Schooling in India Education

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • On the eve of World Cancer Day, Global Healthcare Advisor Vijay Dhawangale shares his views on awareness in the fight against cancer Health
  • Vedanta’s BALCO Medical Centre Puts Spotlight on Cancer Prevention and Multidisciplinary Collaboration for Cancer Care Health
  • Emcure Enters Asia Book of Records with 5,139 Doctors Pledge to Support Dancing to Fight Against Hypertension Health
  • ACTIZEET Shilajit Emerges as the Pinnacle of Potency: 5x More Powerful than Other Shilajit Variants Health
  • Hairsncares: Revolutionizing Hair Health with a Holistic Digital Approach Health
  • Reinventing Success: Dr. Shama’s Revolutionary Impact on Mental Health Tech & Skill Enhancement Health

Recent Posts

  • Sachin Tendulkar Joins SML Limited as Brand Ambassador to Strengthen Trust-Led Growth in Indian Agriculture
  • Konkan Estates Honoured as Gems of Maharashtra 2026 by Shri. Mangal Prabhat Lodha in Mumbai
  • Analytics Insight’s Indian Tech Funding Q2 2026 Report: Non-VC Capital Gains Ground as India Startups Raise $4.37B in Q2 2026
  • Best Crypto Presale: AlphaPepe Takes #1 Spot with Live Product as Investors Ditch Unverified Projects
  • SOMS 2026 Concludes Successfully in Gandhinagar, Highlights Innovation and Self-Reliance in India’s Specialty Fertilizer Sector

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Ruchi Gujjar Dazzles in a Stunning Gown, Dominates IFFI Goa 2025 Lifestyle
  • United Services Institute (USI) hosts a successful Seminar on China, Trishakti Manthan Business
  • Kamala Ankibai Ghamandiram Gowani Trust Recognized for Exemplary Contributions at Elite 50’s Most Influential Indians Awards in New York City National
  • Apple AI Wearable Pin Is Poised to Boldly Shake Up Tech in 2027 Technology
  • FALISHA ENTERTAINMENT celebrating Bharat Ratna Lata Mangeshkars 93rd birth anniversary with live concert, “Geet-O-Ghazal Ki Sarita Hamari Lata” Entertainment
  • AM/NS India’s Hazira Facility Produces ABS-Certified EQ70 Welded Pipes, Marking a Key Step for Offshore Manufacturing Business
  • Parul University’s Vice President and Medical Director Dr. Geetika Madan Patel Highlights The Need for Holistic Stroke Rehabilitation in India Education
  • Motion Education registers exemplary performance with 70.53% qualification rate in JEE Main Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme